Qiming Venture Partners
Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Qiming Venture Partners Information
Geographic Data
Address: Room3906 Jinmao Tower
City: Shanghai
State: shanghai municipality
Zip: 200121
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,312,265Website Global Rank
8,132Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners is a venture capital firm that specializes in building new companies in China. Since their establishment, they have been investing in the TMT and healthcare industries at the early and growing stages. Founded in 2006 by Gary Rieschel, Qiming Venture Partners based in Shanghai, Shanghai.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | Yidao Biotechnology | Series C | 61.8M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 6/2020 | Kingsware | Series A | 14.7M |
| 5/2022 | Point One | Series B | 36.8M |
| 3/2021 | Delta Medical | Series E | 20.1M |
| 8/2019 | Delta Medical | Series C | 7.1M |
| 9/2021 | XSKY Data Technology | Series E | 0 |
| 6/2016 | AIQI Technology | Venture Round | 7M |
| 7/2021 | Liangyihui | Series C | 55.9M |
| 11/2019 | Nice Tuan | Series B | 60.4M |
| 8/2015 | Linjia.me | Series B | - |
| 12/2016 | ANXIN | Series B | 42.7M |
| 4/2012 | ITutorGroup | Series A | 15M |
| 12/2021 | Gemsouls | Series A | 4M |
| 1/2021 | Erwan Technology | Series D | - |
| 10/2021 | Cubenergy Technology | Series A | - |
| 3/2021 | YUANBAO TECH | Series C | 80M |
| 8/2012 | CooTek | Series A | 4.2M |
| 2/2021 | Plum | Series B | 9.1M |
| 1/2022 | MKSEMI | Pre-Series A | 12.8M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 12/2014 | LanzaTech | Series D | 0 |
| 11/2013 | LanzaTech | Series C | 0 |
| 8/2021 | WeRide | Secondary Market | 2M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 8/2017 | ABC Fintech | Series A | 30M |
| 5/2015 | Coohua | Series B | 20M |
| 7/2015 | Bilibili | Series C | 161.4M |
| 10/2016 | Bondent Technology | Series A | 9M |
| 9/2007 | Gaoxing Co., Ltd | Series A | - |
| 3/2021 | Casela | Series A | 2.8M |
| 3/2020 | Berry Oncology | Series A | 10M |
| 10/2013 | Unisound | Series A | 16.3M |
| 3/2021 | MediLink-Global | Series A | 36.9M |
| 1/2021 | Cornerstone Robotics | Series A | 17M |
| 12/2021 | PoPop World | Seed Round | 0 |
| 1/2015 | APUS Group | Series B | 100M |
| 11/2006 | Kuwo Science and Technology | Series A | 5.5M |
| 2/2022 | Purui | Seed Round | 15.7M |
| 5/2011 | Gan &a; Lee Pharmaceutical | Series B | 30.2M |
| 4/2021 | ZSHK Laboratories | Series A | 15.5M |
| 8/2010 | BTR | Series A | 1.6M |
| 2/2012 | Gan &a; Lee Pharmaceutical | Series B | - |
| 1/2020 | DST Car | Series C | - |
| 6/2013 | Venus MedTech | Series A | 17M |
| 9/2017 | Zaojiu | Series A | 5.2M |
| 3/2018 | Zaojiu | Series A | 4.7M |
| 12/2019 | Woof | Series A | 7M |
| 12/2018 | Woof | Series A | 5.8M |
| 4/2017 | Bomming Vision | Series A | 4.4M |
| 1/2018 | Bomming Vision | Series A | 1.5M |
| 8/2018 | CureGenetics | Series A | 17M |
| 1/2019 | V Light | Series A | 2.5M |
| 9/2021 | V Light | Series A | 7M |
| 5/2014 | VINNO Technology | Series B | 7.7M |
| 5/2018 | Tisenc | Series A | 6.3M |
| 6/2009 | Taomee | Series A | - |
| 2/2023 | Hochuen Medical Technology | Series B | - |
| 3/2005 | b2c.cn | Series A | 3M |
| 10/2014 | Coohua | Series A | 4.9M |
| 12/2007 | Topone | Series C | 50M |
| 5/2018 | Philm | Series B | 7M |
| 9/2021 | PlusLife Biotech | Series A | 14.9M |
| 7/2021 | NEIWAI | Series D | 100M |
| 10/2019 | NEIWAI | Series C | 18M |
| 1/2007 | Tianyuan Bio-Pharmaceutical | Series A | - |
| 3/2013 | JHT TCM Clinics | Series A | 2.2M |
| 10/2018 | WeRide | Series A | - |
| 3/2015 | BBI Life Sciences | Post-IPO Equity | 10.3M |
| 9/2019 | QwikMatch | Debt Financing | 1.4M |
| 2/2015 | Helijia | Series C | 50M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 5/2017 | ET Healthcare | Venture Round | 7M |
| 4/2015 | Zai Lab | Series A | 18.3M |
| 3/2019 | Gohoo | Series A | 10.6M |
| 11/2015 | Zhihu | Series C | 55M |
| 1/2017 | CooTek | Series D | 66M |
| 8/2013 | LP Amina | Series C | 20M |
| 1/2023 | Insyce | Series B | 21.8M |
| 1/2017 | Bondent Technology | Series B | - |
| 11/2019 | 61Draw.com | Series B | 11M |
| 2/2008 | Ether Optronics (Suzhou) Co., Ltd. | Venture Round | - |
| 8/2019 | TUNGEE | Series B | 17.7M |
| 9/2017 | SinoVision Technologies | Series B | 29M |
| 1/2021 | Erwan Technology | Series E | - |
| 2/2014 | VANCL | Series G | 100M |
| 10/2019 | Club Factory | Series D | 100M |
| 7/2017 | Qiagen Suzhou Translational Medicine | Series A | 0 |
| 7/2015 | OneAPM | Series C | 26.7M |
| 11/2021 | Cornerstone Robotics | Series B | 0 |
| 3/2018 | Infervision | Series B | 47.4M |
| 6/2019 | 61Draw.com | Series B | 28M |
| 5/2022 | Yike Polymers | Series B | - |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 1/2015 | Mitralign | Series E | 23M |
| 12/2021 | Wholee | Series B | 69M |
| 2/2022 | NFTGo | Pre-Series A | 6.8M |
| 6/2018 | IDsManager | Series A | 7.8M |
| 5/2021 | Insight Lifetech | Secondary Market | 18.1M |
| 7/2018 | Lanjinrong | Series C | 11.6M |
| 5/2020 | Nice Tuan | Series C | 0 |
| 1/2022 | Axera | Series A | 0 |
| 7/2017 | Bingobox | Series A | 14.7M |
| 11/2018 | Chushou | Venture Round | 8.4M |
| 1/2018 | Bingobox | Series B | 0 |
| 2/2013 | Tujia | Series B | 40M |
| 1/2017 | Chushou | Series C | 57.6M |
| 5/2013 | CSD E.P. Water Service | Series B | - |
| 9/2016 | Zuiyou | Series B | 53M |
| 4/2022 | LTZ Therapeutics | Pre-Series A | 17M |
| 5/2022 | Ashermed | Series B | - |
| 9/2017 | Lagou | Series D | 119.2M |
| 11/2018 | Chomp Cloud | Series B | 13.3M |
| 9/2019 | Platelet BioGenesis | Series A | 26M |
| 6/2008 | LP Amina | Series A | 5M |
| 5/2020 | Microtech Medical | Venture Round | 20M |
| 4/2021 | ET Healthcare | Series G | 105M |
| 9/2020 | Delta Medical | Series D | - |
| 6/2015 | Zhejiang JFK | Angel Round | - |
| 4/2014 | Laguo | Series A | 5M |
| 6/2014 | Zhihu | Series B | 22M |
| 1/2023 | Tingsheng Technology | Series B | 14.7M |
| 10/2018 | DST Car | Series B | 43.1M |
| 8/2014 | Zai Lab | Series A | 10M |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 10/2017 | WeRide | Seed Round | - |
| 7/2017 | AFU | Series C | 9.3M |
| 4/2020 | Shulan Health | Series C | 8.5M |
| 8/2017 | SceneRay | Series C | 19.1M |
| 9/2018 | ET Healthcare | Series C | 17.5M |
| 8/2016 | Xiaoman Technology | Series B | 5.3M |
| 12/2019 | Vongi | Series B | 2.9M |
| 5/2009 | Touchmedia | Series B | 16.2M |
| 7/2014 | Beijing Richen-Force Science &a; Technology | Series B | 4.5M |
| 12/2021 | Xinchuangyuan Semiconductor | Series A | 75.4M |
| 12/2021 | Yunji Technology | Venture Round | 72.2M |
| 3/2020 | Berry Genomics | Post-IPO Equity | 10M |
| 5/2021 | Wonderful | Secondary Market | 1.4M |
| 4/2018 | Bondent Technology | Series C | 12.7M |
| 1/2012 | Qiniu | Series A | - |
| 7/2019 | OneAPM | Venture Round | 1.6M |
| 9/2017 | Infervision | Series B | 18.2M |
| 10/2021 | Qingflow | Series B | 11.8M |
| 12/2015 | UBTech Robotics | Series A | 20M |
| 12/2017 | Eigen | Series B | 18.5M |
| 1/2008 | Crown Bioscience | Venture Round | - |
| 9/2019 | DST Car | Venture Round | 30M |
| 3/2018 | Frontage Laboratories | Funding Round | 32.4M |
| 3/2020 | IntoCare | Series C | 7M |
| 5/2017 | XSKY Data Technology | Series B | 17.4M |
| 3/2020 | CureGenetics | Series A | 9.5M |
| 11/2007 | Dining Secretary | Series B | - |
| 7/2018 | Zuiyou | Series C | 22M |
| 3/2021 | Zhenge Biotech | Series B | 70M |
| 7/2016 | Chaitin Tech | Series A | 4.1M |
| 12/2020 | Compart Systems | Venture Round | 398M |
| 1/2014 | Tuhu | Series B | - |
| 8/2010 | 2Duche | Venture Round | - |
| 9/2018 | Bion Interactive Entertainment Company | Seed Round | 2M |
| 3/2008 | Crown Bioscience | Series B | 3.2M |
| 8/2018 | PangQiu | Series A | 6.1M |
| 1/2018 | Berry Genomics | Post-IPO Equity | 122.7M |
| 6/2013 | Iron Armour | Series A | 5M |
| 8/2021 | Houmo.AI | Seed Round | 46M |
| 11/2012 | YPX Cayman Holdings | Series C | 0 |
| 7/2021 | Kingsware | Series B | 42.4M |
| 5/2021 | MKSEMI | Series A | 12.9M |
| 9/2021 | moodytiger | Series B | 20M |
| 8/2018 | CANbridge Pharmaceuticals | Series C | 38.1M |
| 7/2019 | Xiudan | Seed Round | - |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 12/2014 | Unisound | Series B | 50M |
| 4/2017 | Berry Genomics | Funding Round | 8.1M |
| 2/2019 | Nuvaira | Equity | 79M |
| 7/2016 | CooTek | Series D | 46M |
| 6/2019 | ZD Medical | Series A | 4.5M |
| 9/2018 | IntoCare | Series B | 3.7M |
| 6/2014 | Inbilin | Series A | 15M |
| 9/2021 | Genevide | Angel Round | 6M |
| 4/2019 | WebComics | Venture Round | 785k |
| 3/2014 | Domob | Series C | 2M |
| 1/2010 | eHi Car Rental | Series B | 18.7M |
| 4/2019 | Anxin Doctor | Series B | 3.6M |
| 2/2015 | Amoy Diagnostics | Series A | 10.7M |
| 1/2014 | VR Medical | Series A | 5.5M |
| 6/2009 | Alltech Medical Systems | Series B | 5M |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 3/2008 | eHi Car Rental | Series A | 5M |
| 7/2015 | CMLabs | Series A | 1.1M |
| 1/2016 | 8kana | Series A | 6M |
| 9/2006 | Alltech Medical Systems | Series A | - |
| 11/2015 | Shanghai Keysino Separation Technology | Series A | 7.9M |
| 12/2010 | wali | Series A | 4.6M |
| 7/2014 | CooTek | Series C | 69.3M |
| 4/2014 | APT Medical | Series A | - |
| 9/2017 | Sino Vision | Series B | 30.6M |
| 8/2011 | Arrail Dental Clinic | Series B | 20M |
| 5/2014 | Ants Technology | Series A | 3.5M |
| 3/2016 | Shanghai Rendu Biotechnology | Series B | 2.3M |
| 8/2018 | Jacobio Pharmaceuticals | Series C | 0 |
| 11/2016 | Yinshiji | Series A | - |
| 3/2010 | Tigermed | Venture Round | 2M |
| 2/2014 | Wacai.com | Series A | 15M |
| 2/2019 | Xiaobu | Series B | 12M |
| 4/2019 | Bomming Vision | Series A | 596k |
| 7/2016 | KingTrol Data | Series A | 4.5M |
| 3/2016 | SMTP Technology | Series A | 3.1M |
| 1/2015 | Zhaolu Tianxia Wang | Series A | 1.6M |
| 7/2016 | Junhetang | Series B | 7.9M |
| 1/2016 | AIQI Technology | Series A | - |
| 11/2016 | Chomp Cloud | Series A | 6M |
| 3/2011 | CSD Beijing Water Affairs Op | Venture Round | - |
| 6/2014 | Ants Technology | Series B | 7M |
| 6/2009 | ConvenientPower HK | Series A | 3M |
| 9/2014 | Tuhu | Series B | 10M |
| 3/2019 | Emergen | Series B | 29.8M |
| 1/2018 | Roborock | Series B | 3.4M |
| 3/2020 | Wuli Planet | Series A | 7.5M |
| 6/2018 | Wuli Planet | Seed Round | 2M |
| 4/2016 | Roborock | Series B | 25M |
| 1/2017 | Connect Biopharmaceuticals | Series A | 20M |
| 7/2018 | Kaiheikeji Digital | Series A | 15M |
| 11/2017 | Kaiheikeji Digital | Series A | 11.5M |
| 1/2011 | CSD E.P. Water Service | Venture Round | - |
| 2/2020 | Fingo | Series A | 7M |
| 4/2017 | Qiang Sen International Community Medical | Series B | 14.6M |
| 10/2018 | DK MedTech | Series B | 8.7M |
| 8/2010 | Jiayuan | Series B | - |
| 5/2015 | Junhetang | Series B | - |
| 9/2016 | Hypereal | Series B | 10.5M |
| 7/2020 | HashQuark | Series A | 2M |
| 1/2018 | Chaodian Culture | Seed Round | 723.8k |
| 8/2019 | WorkTrans | Series C | 50.5M |
| 2/2010 | Aeonmed Medical Treatment | Series A | 3.5M |
| 10/2017 | Moretickets | Series B | 25M |
| 6/2017 | Platelet BioGenesis | Series A | 0 |
| 5/2019 | Mafengwo | Series E | 0 |
| 9/2021 | Sanegene Bio | Series A | 38M |
| 2/2020 | Jacobio Pharmaceuticals | Series C | 27M |
| 6/2016 | VeeR (Velocious) | Seed Round | 2M |
| 9/2011 | Slanissue | Venture Round | 10M |
| 5/2019 | Hesai Technology | Series C | 37M |
| 8/2022 | Prismlab China Ltd | Series C | 29.1M |
| 9/2016 | OneAPM | Series D | 19.5M |
| 5/2008 | Kuwo Science and Technology | Series B | - |
| 7/2014 | Intelligent Automation | Series B | 4.2M |
| 4/2009 | Kaixin001 | Series B | 20M |
| 1/2008 | PPS | Series C | 20M |
| 8/2008 | VANCL | Series D | 30M |
| 12/2016 | Luo Tianyi | Series B | 8M |
| 7/2018 | Wacai.com | Series D | 140M |
| 5/2021 | Health Biotech | Series B | 34.5M |
| 5/2021 | TUNGEE | Series C | 148M |
| 9/2018 | Cubenergy Technology | Series A | 7.3M |
| 3/2015 | CashBUS | Series A | - |
| 4/2021 | Castbox | Series C | 15M |
| 7/2016 | LIH Investment &a; Management | Series A | 12M |
| 4/2016 | CanSinoBIO | Venture Round | 11M |
| 3/2018 | Jisuyun | Series B | 11.4M |
| 12/2009 | Gan &a; Lee Pharmaceutical | Series A | 16.2M |
| 11/2018 | Reelsky Data Systems | Series A | 5.4M |
| 4/2021 | ROX Motor | Series A | 60M |
| 12/2018 | FirstGrid | Seed Round | 4.8M |
| 1/2018 | Xiaoman Technology | Series C | 9.7M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 11/2018 | Haoyiku | Series B | - |
| 4/2021 | Booming Technologies | Series C | 56M |
| 5/2019 | Nice Tuan | Series A | 27.9M |
| 1/2020 | Nice Tuan | Series B | 88.3M |
| 6/2013 | Intelligent Automation | Series A | 5.1M |
| 11/2020 | Yunyinggu | Series D | 45.6M |
| 7/2017 | Kira Pharmaceuticals | Series A | 5M |
| 9/2021 | WOWJOY TECHNOLOGY | Series A | 13.6M |
| 3/2022 | ACXEL Tech | Seed Round | 0 |
| 10/2011 | YPX Cayman Holdings | Series B | 20M |
| 2/2022 | WOWJOY TECHNOLOGY | Series A | 10M |
| 3/2018 | Chaonengjie | Seed Round | 2.8M |
| 12/2009 | LP Amina | Series B | 9.4M |
| 4/2007 | Jiayuan | Series A | 5.4M |
| 4/2021 | Zion Pharma | Series B | 37M |
| 4/2016 | Tiebaobei | Series C | 30.9M |
| 3/2015 | Venus MedTech | Series B | 8M |
| 9/2017 | Venus MedTech | Series C | 7.4M |
| 11/2017 | Bioscience | Series C | 15.6M |
| 5/2017 | Vongi | Series A | 6M |
| 6/2021 | Xiaoe Tech | Series D | 120M |
| 6/2015 | SMTP Technology | Series A | 8.1M |
| 5/2018 | The Makers | Series B | 8.5M |
| 3/2013 | Sino MDT | Series A | 4M |
| 5/2018 | Sino Biological | Venture Round | 15.8M |
| 2/2012 | Shanghai Tellgen Life Science | Series A | 5M |
| 3/2020 | Structure Therapeutics | Series A | 26M |
| 9/2017 | ABC Fintech | Series A | 30M |
| 3/2018 | ACEA BIO | Series E | 15M |
| 12/2021 | DP Technology | Series B | 43.7M |
| 12/2017 | Koala Reading | Series A | 10M |
| 7/2014 | MEGVII | Series B | 22M |
| 3/2022 | BlockVision | Seed | 5M |
| 8/2018 | Koala Reading | Series B | 20M |
| 8/2014 | Laguo | Series B | 25M |
| 2/2020 | Kira Pharmaceuticals | Series B | 28M |
| 2/2012 | Touchmedia | Series C | 16.2M |
| 7/2022 | Chatail | Series B | 10M |
| 8/2022 | DeepWay | Series A | 67.2M |
| 5/2011 | Crown Bioscience | Series C | 28.8M |
| 2/2021 | Miaoshou Doctor | Series E | 0 |
| 8/2017 | Chomp Cloud | Series A | 7M |
| 6/2012 | Forgame | Private Equity Round | 68.8M |
| 5/2010 | 7k7k.com | Angel Round | 1.1M |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 5/2022 | BUD | Series B | 0 |
| 12/2017 | Meituan Bike | Corporate Round | - |
| 7/2018 | Qingqi Technology | Angel Round | - |
| 7/2017 | OPUS | Angel Round | 1M |
| 11/2018 | Guji Information | Angel Round | 287.9k |
| 5/2010 | Mutto Optronics | Venture Round | - |
| 11/2011 | Leho | Venture Round | 50M |
| 10/2017 | Jacobio Pharmaceuticals | Venture Round | 19.6M |
| 4/2007 | Huan Xiong | Venture Round | 1.8M |
| 4/2022 | Clique | Seed Round | - |
| 4/2016 | Xueda | Post-IPO Equity | - |
| 8/2015 | Tuhu | Series C | 0 |
| 8/2019 | RedDoorz | Series C | 0 |
| 12/2016 | MEGVII | Series C | 100M |
| 3/2016 | Lagou | Series C | 34M |
| 1/2016 | Qiniu | Series D | 100M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 9/2019 | TigerGraph | Series B | 32M |
| 4/2011 | Dazhong Dianping | Series C | 100M |
| 4/2018 | CMLabs | Series C | 15.9M |
| 10/2020 | Broncus Technologies | Series C | - |
| 4/2014 | Arrail Dental Clinic | Series C | 70M |
| 4/2018 | Wuxi Vision Pro | Series B | 14.2M |
| 10/2013 | BSC | Series A | 1.6M |
| 10/2014 | WeDoctor | Series B | 106.5M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 4/2019 | Talaris Therapeutics | Series A | 100M |
| 7/2022 | PwnedNoMore | Seed Round | - |
| 2/2013 | Qiniu | Series B | 4.2M |
| 12/2017 | QwikMatch | Series B | 6M |
| 6/2020 | Miaoshou Doctor | Series D | 85M |
| 10/2018 | NASN Automotive Electronics | Series A | 14.4M |
| 1/2017 | Microtech Medical | Series B | 12.2M |
| 6/2019 | Liuyi Jiaoyu | Series B | 2.9M |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 1/2017 | Xueba100.com | Series C | 100M |
| 2/2015 | Xueba100.com | Series B | 50M |
| 5/2015 | FraudMetrix | Series B | 30M |
| 1/2022 | CureGenetics | Series B | 0 |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 6/2018 | WindMIL Therapeutics | Series B | 0 |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 10/2018 | CardiaLen | Series B | 17M |
| 8/2021 | Berry Oncology | Series B | 99.2M |
| 12/2014 | Wacai.com | Series B | 50M |
| 7/2019 | Yuanxin Huibao | Series A | 7.3M |
| 10/2020 | Cool Academy | Series A | 15M |
| 4/2019 | Mech-Mind | Series A | 50M |
| 3/2021 | Cool Academy | Series B | 18.9M |
| 10/2008 | Novast | Series B | 50M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 1/2013 | Tuhu | Series A | - |
| 2/2020 | Bouffalo Lab | Series B | 26M |
| 4/2018 | XSKY Data Technology | Series C | 37.8M |
| 9/2021 | Sunyur | Series B | 0 |
| 6/2014 | Tujia | Series C | 100M |
| 5/2020 | Alamar Biosciences | Series A | 14M |
| 10/2007 | Guokang Health Management | Series A | 10M |
| 8/2022 | GluBio Therapeutics | Series A | 22M |
| 9/2017 | Hypereal | Series C | 11.8M |
| 4/2013 | Shenzhen LETEL Technology | Series A | 5.9M |
| 3/2018 | DST Car | Series A | 47.8M |
| 7/2021 | Insight Lifetech | Series D | 85M |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 11/2017 | Berry Oncology | Series A | 121.2M |
| 1/2022 | Ceptur Therapeutics | Series A | 0 |
| 9/2012 | Mafengwo | Series B | 15M |
| 11/2021 | ROX Motor | Series C | 100M |
| 6/2018 | Xiaoy Technology | Series B | 4.7M |
| 9/2011 | Beijing Centre Biology | Series A | 7.4M |
| 8/2018 | TUNGEE | Series A | 6.3M |
| 8/2018 | Nice Tuan | Seed Round | 0 |
| 9/2011 | Beva | Series A | 3.1M |
| 12/2014 | CANbridge Pharmaceuticals | Series A | 10M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 9/2015 | Wealth Bridge | Series C | - |
| 8/2011 | Nurotron Biotechnology | Series B | 6.9M |
| 11/2014 | Nurotron Biotechnology | Series C | 1.2M |
| 3/2021 | imToken | Series B | 30M |
| 5/2008 | Oriental Cambridge Education Group | Venture Round | 1M |
| 3/2022 | Medilink Therapeutics | Series B | 70M |
| 9/2018 | MicroPoint Bioscience | Series E | 109M |
| 3/2019 | RedDoorz | Series B | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 1/2017 | Shenogen Pharma Group | Series D | 45M |
| 4/2021 | SinoUnited Health Clinic | Series C | 30.7M |
| 8/2014 | Qiniu | Series C | - |
| 12/2018 | Microtech Medical | Series C | 29.1M |
| 6/2019 | Pratilipi | Series B | 15.2M |
| 10/2017 | Bang Er Orthopedic | Series C | 33.9M |
| 1/2023 | Yike Polymers | Series B | - |
| 1/2022 | WoXiaoYa | Series B | - |
| 5/2019 | SinoUnited Health Clinic | Series B | 9.3M |
| 5/2018 | Heika | Series B | 10.3M |
| 7/2019 | Dingdong Maicai | Series B | - |
| 12/2019 | Newsoara | Series B | 22M |
| 6/2017 | Miaoshou Doctor | Series B | 10.9M |
| 3/2016 | JHT TCM Clinics | Series B | 1.5M |
| 4/2019 | INXX | Series B | 16.5M |
| 11/2015 | ET Healthcare | Series B | - |
| 3/2018 | Coffee Box | Series B | 88M |
| 6/2016 | CMLabs | Series B | 14.1M |
| 8/2018 | ANXIN | Series B | 19.1M |
| 2/2019 | Zuiyou | Series C | 80M |
| 4/2021 | Alpha Biopharma | Series B | 25M |
| 7/2008 | Tigermed | Series A | 6.3M |
| 7/2017 | Sino Biological | Series A | 29.4M |
| 3/2016 | Seven Kilometers | Series A | 5M |
| 12/2014 | SequoiaDB | Series A | 10M |
| 3/2014 | Sanyou Medical | Series A | - |
| 2/2016 | Microtech Medical | Series A | 24.3M |
| 3/2019 | LuPu Investment | Series A | 44.6M |
| 12/2014 | Luoji Siwei | Series A | - |
| 3/2010 | Arrail Dental Clinic | Series A | 20M |
| 1/2017 | Qkuts | Seed Round | 1M |
| 6/2018 | Pop Game | Seed Round | - |
| 8/2021 | Neuro3 Therapeutics | Seed Round | 10M |
| 11/2013 | Meitu | Seed Round | 5M |
| 4/2018 | Meituan | Venture Round | - |
| 12/2021 | Frontis | Seed Round | 18.4M |
| 11/2021 | Bioyond Tech | Seed Round | 7.8M |
| 7/2020 | XSKY Data Technology | Series D | 33M |
| 12/2019 | SinoUnited Health Clinic | Series C | 8.1M |
| 5/2013 | Berry Genomics | Series B | 14.7M |
| 7/2016 | SequoiaDB | Series B | 10M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 8/2010 | eHi Car Rental | Series C | 70M |
| 2/2020 | InfStones | Series A | 10M |
| 1/2008 | 9DIAMOND | Series A | 9.6M |
| 4/2022 | CIX Technology | Angel Round | - |
| 11/2021 | Platelet BioGenesis | Series B | 75.5M |
| 7/2018 | Madaket | Series B | 0 |
| 1/2021 | Vistel | Series B | 9.3M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 5/2017 | Wacai.com | Series C | 0 |
| 1/2015 | Bilibili | Series B | 44.2M |
| 7/2015 | Zhaolu Tianxia Wang | Series B | 3.2M |
| 6/2006 | Fangtek | Series C | 12M |
| 12/2020 | WT Microtech Medical | Series D | 0 |
| 1/2015 | Zhaosuliao | Series A | 20M |
| 7/2017 | Akulaku | Series B | 24.8M |
| 7/2015 | Wacai.com | Series B | 80M |
| 12/2015 | HyperStrong | Series A | 20.3M |
| 3/2013 | Origene Technologies | Series C | 21.3M |
| 6/2014 | MOGU | Series D | 200M |
| 4/2016 | ACEA BIO | Series E | 6M |
| 5/2014 | Crown Bioscience | Series D | 26.6M |
| 8/2020 | Connect Biopharmaceuticals | Series C | 115M |
| 9/2021 | XellSmart | Seed Round | 11.9M |
| 1/2023 | Biotree | Series A | - |
| 2/2017 | Ark Biosciences | Series A | 8M |
| 6/2018 | Ark Biosciences | Series B | 32M |
| 4/2021 | Gaugene | Series A | 4.6M |
| 3/2015 | Mafengwo | Series C | 100M |
| 11/2011 | Zhihu | Series A | 8M |
| 4/2019 | Coffee Box | Series B | 30.6M |
| 1/2017 | Zhihu | Series D | 103.3M |
| 7/2018 | Moretickets | Series C | 61.7M |
| 10/2019 | dMed | Series B | 50M |
| 11/2018 | WorkTrans | Series B | 23M |
| 8/2021 | Matrixport | Series C | 0 |
| 1/2021 | WeRide | Series B | 0 |
| 1/2022 | EigenCOMM | Series C | 157.3M |
| 1/2019 | NASN Automotive Electronics | Series B | 59.6M |
| 8/2013 | Shenogen Pharma Group | Series C | 20M |
| 9/2019 | DST Car | Venture Round | 30M |
| 5/2019 | ZuzuChe | Series C | 26.1M |
| 7/2011 | Fanli | Series A | 10M |
| 5/2021 | Valgen Medtech | Series B | 188M |
| 9/2008 | ChinaCache | Series C | - |
| 11/2015 | ACEA BIO | Venture Round | 30M |
| 12/2016 | WT Microtech Medical | Series B | - |
| 4/2016 | Insta360 | Series B | - |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 9/2020 | InventisBio | Series D | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 3/2019 | Abbisko Therapeutics | Series B | 42M |
| 5/2016 | Bilibili | Series C | 199.3M |
| 7/2011 | Xiaomi | Series A | 41M |
| 12/2011 | Xiaomi | Series B | 90M |
| 4/2008 | Nurien Software | Series A | 15M |
| 7/2011 | VANCL | Series F | 230M |
| 5/2016 | Musical.ly | Series C | 133.5M |
| 11/2017 | Twine Health | Series A | 1.5M |
| 4/2021 | Axera | Seed Round | - |
| 7/2015 | Tiebaobei | Series B | 16.2M |
| 11/2013 | Tiebaobei | Series A | - |
| 5/2017 | Sinocelltech | Series A | 29M |
| 12/2014 | Meitu | Series C | 190M |
| 10/2021 | Clounix | Angel Round | - |
| 11/2021 | GenEdit | Angel Round | 9M |
| 11/2019 | Genius | Series B | 14.2M |
| 4/2021 | Abogen Biosciences | Series B | 91.6M |
| 1/2022 | Zhenge Biotech | Series C | 100M |
| 7/2021 | Petkit | Series D | 60M |
| 2/2019 | Petkit | Series C | 20M |
| 9/2020 | Petkit | Series C | - |
| 6/2021 | Hesai Technology | Series D | 300M |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 10/2015 | CANbridge Pharmaceuticals | Series A | 10M |
| 3/2018 | LetsGetChecked | Series A | 12M |
| 2/2014 | ITutorGroup | Series B | 100M |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 6/2009 | Novast | Series B | 25M |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 1/2009 | Nurien Software | Series A | 10M |
| 6/2012 | Xiaomi | Series C | 216M |
| 4/2019 | Structure Therapeutics | Series A | 16M |
| 3/2023 | TandemAI | Series A | 0 |
| 6/2017 | Zai Lab | Series C | 30M |
| 7/2017 | Kezar Life Sciences | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2021 | Abbisko Therapeutics | Series D | 123M |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 11/2015 | CanSinoBIO | Series C | 30M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 2/2017 | Jacobio Pharmaceuticals | Series B | - |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 9/2022 | XellSmart | Series A | - |
| 1/2019 | Schrödinger | Series E | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 9/2018 | SequoiaDB | Series C | 0 |
| 12/2017 | Tiebaobei | Series C | - |
| 8/2022 | OriginCell | Series B | 0 |
| 12/2019 | OriginCell | Series A | 7.1M |
| 11/2018 | Genor Biopharma | Venture Round | 276.7M |
| 3/2020 | Abbisko Therapeutics | Series C | 70M |
| 12/2016 | Shulan Health | Series B | 31.2M |
| 8/2017 | New Horizon Health | Series B | 20M |
| 1/2023 | Singular Medical | Series B | - |
| 2/2021 | Liangyihui | Series C | 0 |
| 12/2019 | Clinflash Heathcare Technology | Series A | 4.3M |
| 3/2020 | Xueba100.com | Convertible Note | 22.7M |
| 9/2019 | Hesai Technology | Series C | 1.1M |
| 1/2010 | YPX Cayman Holdings | Series A | 10M |
| 12/2016 | Finern | Series A | 7.3M |
| 3/2021 | IntoCare | Secondary Market | 4.3M |
| 3/2020 | ShouTi | Series A | 26M |
| 6/2015 | Cehome | Series B | 2.5M |
| 1/2016 | HyperStrong | Series B | 68.5M |
| 5/2014 | Broncus Technologies | Venture Round | 4.3M |
| 10/2008 | T4GAME | Series A | 3M |
| 12/2018 | Xiudan | Seed Round | 3M |
| 6/2021 | BrainHealth | Series C | 72.4M |
| 3/2015 | Bioon.com | Series A | 2.9M |
| 2/2021 | Wholee | Series A | 10k |
| 12/2021 | Clinflash Heathcare Technology | Venture Round | 15.5M |
| 5/2018 | Bang Er Orthopedic | Series C | 15.8M |
| 4/2018 | KangBai | Series A | 3.7M |
| 3/2021 | Basecamp Bio | Angel Round | 14M |
| 8/2021 | Yunqi | Seed Round | 31M |
| 7/2013 | Hortor | Series A | 2.5M |
| 12/2021 | Sinogen Biopharma | Venture Round | 3M |
| 11/2018 | Mucho Indonesia | Seed Round | 3M |
| 9/2021 | ROX Motor | Series B | 60M |
| 12/2011 | Beijing GoodWill Technology | Series A | 4.2M |
| 5/2019 | Zaojiu | Venture Round | 2M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 5/2017 | DST Car | Seed Round | 7.3M |
| 11/2018 | Webuy Group | Series B | 15.8M |
| 8/2016 | Xiutao | Seed Round | 1.5M |
| 10/2015 | Wuxi Vision Pro | Series A | 4.8M |
| 8/2021 | Lingyi Zhihui | Series B | 0 |
| 11/2018 | WebComics | Seed Round | 3.2M |
| 12/2019 | Inbilin | Venture Round | - |
| 9/2019 | Plum | Series B | 0 |
| 9/2018 | Aohua | Series D | 43.7M |
| 1/2016 | Aohua | Series C | 30.8M |
| 3/2018 | V Light | Seed Round | 1M |
| 7/2015 | Lanmi | Series A | 5M |
| 4/2022 | Rhino Health | Venture Round | 5.7M |
| 6/2013 | VINNO Technology | Series A | 5.8M |
| 8/2017 | Antengene Corporation | Series A | 21M |
| 7/2020 | New Horizon Health | Series E | 30M |
| 7/2018 | dMed | Series B | 6M |
| 1/2020 | Chushou | Debt Financing | 4M |
| 3/2019 | ACEA BIO | Venture Round | 20M |
| 7/2010 | Sangon Biotech | Series A | 6.2M |
| 1/2018 | Chushou | Series D | 47.5M |
| 2/2017 | Anxin Doctor | Series B | 29.1M |
| 2/2017 | Anssure Pharma | Series A | 8.7M |
| 3/2008 | Touchmedia | Series B | 14.2M |
| 4/2020 | Belief Biomed | Series B | 84M |
| 2/2021 | Saints Sages Medical | Series A | 18.6M |
| 9/2017 | VR Medical | Series B | 3M |
| 9/2019 | Tisenc | Series B | 11.2M |
| 3/2015 | Insta360 | Series A | 8M |
| 11/2021 | Micropace | Series A | 5.5M |
| 8/2006 | Touchmedia | Series A | - |
| 4/2021 | Unisound | Series D | 60M |
| 8/2018 | APT Medical | Series B | 11.1M |
| 1/2005 | Gammastar Medical Group | Series A | 8.7M |
| 8/2018 | Cool Math | Series A | 10M |
| 5/2021 | IntoCare | Series D | 43.2M |
| 5/2010 | ChinaCache | Post-IPO Equity | - |
| 11/2021 | Beijing Okeanos Technology | Series B | 22.4M |
| 5/2021 | Data Transmission Group | Secondary Market | 9.3M |
| 12/2017 | Cehome | Series D | 44M |
| 8/2021 | Superhexa | Seed Round | 9.9M |
| 12/2021 | Superhexa | Series A | 28M |
| 10/2013 | Dajiabao | Series A | - |
| 8/2022 | Oricell Therapeutics | Series B | 120M |
| 12/2013 | Shanghai Rendu Biotechnology | Series B | 10.3M |
| 9/2007 | Juren Educational | Venture Round | 20M |
| 10/2017 | SGEET | Series A | 7.5M |
| 5/2014 | Meitu | Series B | 115M |
| 12/2019 | Yuanxin Huibao | Series A | 4.3M |
| 7/2018 | ZEGOCLOUD | Series B | 16M |
| 8/2017 | Kintep Environmental | Series B | 5.6M |
| 5/2013 | Cehome | Series A | 2M |
| 6/2011 | Novast | Series C | 2.9M |
| 5/2021 | MeetFuture China | Series A | 12.3M |
| 1/2021 | Oricell Therapeutics | Series A | 0 |
| 4/2015 | HaiRun Pictures | Series A | 11.3M |
| 11/2010 | Guokang Health Management | Series B | 14.9M |
| 1/2021 | RFoneTech | Series A | 4.6M |
| 10/2016 | Broncus Technologies | Series A | 12.2M |
| 12/2017 | Xiaobu | Series B | 14M |
| 8/2019 | Haoyiku | Series C | 100M |
| 10/2017 | Gaiya Environment | Series A | 6.1M |
| 10/2021 | Clounix | Seed Round | 34.9M |
| 4/2015 | Fortune International Factoring | Series A | 16.2M |
| 5/2018 | Hanqi | Series A | 6.3M |
| 7/2019 | Chuman | Series B | 8.7M |
| 11/2017 | Chuman | Series A | 8.3M |
| 5/2021 | Render | Series A | 15.5M |
| 9/2011 | Novast | Series D | 2M |
| 8/2018 | Plum | Series B | 21.4M |
| 4/2017 | IntoCare | Series A | 26M |
| 12/2011 | Appconomy | Series B | 10M |
| 12/2021 | InfStones | Series B | 33M |
| 2/2021 | Morewis | Series B | 9.3M |
| 9/2009 | 60DXchange | Venture Round | - |
| 6/2017 | SinoTau | Series B | 22M |
| 2/2021 | Singular Medical | Series B | 24M |
| 4/2021 | P&a;R Measurement Technology | Series C | 23.9M |
| 2/2018 | P&a;R Measurement Technology | Series A | 9.9M |
| 7/2010 | LanzaTech | Series B | 18M |
| 12/2019 | Oricell Therapeutics | Seed Round | 14.2M |
| 4/2017 | CanSinoBIO | Series E | 0 |
| 12/2021 | TUNGEE | Series B | 0 |
| 1/2020 | DST Car | Series C | - |
| 8/2018 | Kira Pharmaceuticals | Series A | 13M |
| 11/2020 | LaNova Medicines | Series A | 84.4M |
| 10/2018 | DST Car | Series B | 47.4M |
| 3/2022 | MeetFuture China | Series B | 0 |
| 3/2020 | Singular Medical | Series A | 10M |
| 8/2016 | Ruhnn Holding Limited | Series C | - |
| 3/2016 | Cehome | Series C | 25M |
| 1/2017 | Diandoc | Seed Round | 1M |
| 9/2017 | TigerGraph | Series A | 31M |
| 7/2020 | Antengene Corporation | Series C | 97M |
| 9/2015 | Oakbarrel | Series B | 3.1M |
| 9/2009 | Jiayuan | Series B | - |
| 5/2018 | Xueba100.com | Series D | 22.5M |
| 10/2010 | Dang Le | Series A | 12M |
| 11/2018 | Eigen | Series B | 6.6M |
| 2/2009 | Youxigu | Series A | - |
| 2/2017 | LIH Investment &a; Management | Series A | 5.8M |
| 12/2018 | Try Try | Series A | 7M |
| 4/2016 | AirQuality | Series B | 4M |
| 6/2016 | JunHe | Series B | 7.6M |
| 7/2020 | 52toys | Secondary Market | 2M |
| 3/2019 | 52toys | Series A | 447.3k |
| 3/2018 | 52toys | Series A | 14.6M |
| 4/2020 | DiNovA Medtech | Series C | 17M |
| 4/2017 | ByteDance | Series D | 1B |
| 12/2020 | dMed | Series C | 100M |
| 12/2016 | dMed | Series A | 8M |
| 7/2021 | Hochuen Medical Technology | Series A | 6.2M |
| 1/2012 | MOGU | Series B | 10M |
| 10/2012 | MOGU | Series C | - |
| 4/2018 | ZD Medical | Series A | 16.7M |
| 4/2017 | ZappRx | Series B | 25M |
| 11/2021 | Genlight | Series B | 31.4M |
| 7/2018 | The Good Stuff | Series B | 50M |
| 8/2014 | Lagou | Series B | 25M |
| 12/2015 | Aerospace Environment | Series A | 1.3M |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 11/2010 | Docin | Series B | - |
| 12/2008 | Docin | Series A | 1M |
| 6/2017 | Chaitin Tech | Series A | 4M |
| 6/2019 | Pulsar Technology | Series A | - |
| 1/2020 | Sunny Dental | Series A | 28.7M |
| 6/2015 | Financial Information Management | Series A | 6M |
| 12/2019 | Chaodian Culture | Series B | 150M |
| 12/2018 | Chaodian Culture | Series A | 5.5M |
| 12/2016 | CETA | Series A | 4.4M |
| 3/2018 | Bouffalo Lab | Series A | 7M |
| 10/2017 | Castbox | Series A | 12.8M |
| 3/2016 | CashBUS | Series B | 25M |
| 8/2020 | Shukun Technology | Series B | 0 |
| 9/2013 | Tiangua Online | Series B | 1M |
| 1/2018 | Innostic | Series A | 39.5M |
| 4/2021 | Xizi Education | Series A | 22M |
| 10/2015 | JFK Biotech | Angel Round | 472.7k |
| 8/2019 | Bondent Technology | Series D | - |
| 5/2021 | Just Medical | Series B | 34M |
| 12/2009 | CITIC Pharmaceutical | Series D | 1M |
| 3/2021 | Fucunbao | Series C | 11.4M |
| 6/2020 | Shukun Technology | Series B | 0 |
| 6/2018 | RENS Energy | Angel Round | 1M |
| 2/2015 | Aerospace Environment | Series A | - |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 9/2021 | GYENNO Technologies | Series B | 17.3M |
| 4/2020 | New Horizon Health | Series D | 20M |
| 2/2016 | Transwarp | Series B | 23.6M |
| 1/2015 | Transwarp | Series A | 5.1M |
| 6/2022 | LaNova Medicines | Series B | - |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 10/2016 | APT Medical | Series A | 3.6M |
| 8/2019 | APT Medical | Venture Round | 27.2M |
| 11/2018 | APT Medical | Series C | 19.2M |
| 3/2015 | Ark Biosciences | Series A | - |
| 11/2021 | Suci Technology | Series A | 8.3M |
| 10/2012 | CooTek | Series B | 8.2M |
| 9/2019 | Yunyinggu | Series C | 22M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 6/2011 | Domob | Series B | 20M |
| 4/2018 | Castbox | Series B | 13.5M |
| 4/2020 | Yunyinggu | Series C | 28.2M |
| 12/2015 | Nurotron Biotechnology | Series C | - |
| 10/2015 | Luoji Siwei | Series B | - |
| 5/2021 | Hope Medicine | Series B | 56M |
| 4/2020 | Chuhang Tech | Series A | 6.4M |
| 4/2021 | Sincere Edu | Series A | 13M |
| 11/2021 | Shanzhen | Series D | 17M |
| 9/2019 | Shanzhen | Series D | 30M |
| 5/2022 | AskGene Pharma | Series A | 20M |
| 12/2018 | YI Technology | Venture Round | 10M |
| 7/2016 | UBTech Robotics | Series B | 100M |
| 4/2015 | UBTech Robotics | Series A | - |
| 4/2012 | Dang Le | Series B | 20M |
| 11/2020 | Nice Tuan | Series C | 0 |
| 5/2011 | Crown Bioscience | Venture Round | 1M |
| 11/2021 | Atom Semiconductor | Venture Round | 12M |
| 7/2020 | TUNGEE | Series B | 17.2M |
| 3/2020 | NVX Clouds Tech | Series A | 3.9M |
| 5/2015 | MedSci | Series A | 14.9M |
| 8/2018 | Chaodian Culture | Angel Round | - |
| 4/2020 | Pratilipi | Series C | 0 |
| 4/2018 | Miaoshou Doctor | Series C | 79.6M |
| 8/2019 | Webuy Group | Series C | 100M |
| 9/2016 | Meituan Bike | Series C | - |
| 4/2022 | Onechip Bioelectronics | Series B | 23.5M |
| 9/2018 | Tuhu | Series E | 0 |
| 6/2017 | Meituan Bike | Series E | 600M |
| 11/2020 | ZEGOCLOUD | Venture Round | 50M |
| 1/2021 | Yunji Technology | Series C | 0 |
| 1/2017 | Meituan Bike | Series D | 215M |
| 2/2022 | BUD | Series A | 15M |
| 5/2015 | Tongdun Technology | Series B | 30M |
| 3/2021 | Hangzhou Weier | Series B | 15.5M |
| 1/2012 | Timesafer | Series A | - |
| 4/2007 | ChinaCache | Series B | 31.5M |
| 12/2009 | ChinaCache | Series D | - |
| 4/2021 | Tasogare | Series B | 41.1M |
| 9/2015 | Roborock | Angel Round | - |
| 3/2016 | SharpSpring | Post-IPO Equity | - |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 5/2019 | Chuhang Tech | Series A | 4.5M |
| 11/2021 | Zeen Health | Venture Round | 6.3M |
| 5/2021 | TUNGEE | Venture Round | 148M |
| 3/2007 | PPS | Series B | 10M |
| 12/2017 | Mafengwo | Series D | 133M |
| 4/2018 | Chaodian Culture | Series A | 12.6M |
| 12/2013 | Nurotron Biotechnology | Series C | 16.2M |
| 6/2007 | ICE Entertainment | Series A | 8.5M |
| 7/2022 | Biotree | Series A | 13.3M |
| 6/2020 | OriginCell | Series A | 8.4M |
| 7/2018 | AI Prime | Angel Round | 1M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 3/2021 | Newsoara | Series C | 7M |
| 7/2018 | Core Medical | Series A | 4.4M |
| 10/2018 | Akulaku | Series C | 0 |
| 12/2016 | Cencorp Automation | Series A | 10.5M |
| 7/2012 | Beijing Centre Biology | Series B | 2.6M |
| 10/2019 | Casela | Series A | 16.7M |
| 6/2020 | Biren Technology | Series A | 0 |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 1/2022 | Deep View Technology | Series B | - |
| 9/2022 | Supervision Technology | Seed Round | - |
| 4/2016 | FraudMetrix | Series C | - |
| 6/2015 | Shenogen Pharma Group | Series D | 2.1M |
| 12/2019 | DiNovA Medtech | Series C | 24.6M |
| 11/2019 | Liuyi Jiaoyu | Series B | 0 |
| 11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 5/2019 | LetsGetChecked | Series B | 0 |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 3/2019 | Insta360 | Series C | 0 |
| 8/2022 | GluBio Therapeutics | Series A | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 8/2022 | Oricell Therapeutics | Series B | 0 |
| 7/2022 | Chatail | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 7/2022 | Biotree | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 6/2022 | LaNova Medicines | Series B | - |
| 6/2022 | Insilico Medicine | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
